Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • Editors Pick
    • Adding Aspirin to...

    Adding Aspirin to Steroid reduces Mortality in TB Meningitis - Indian Study

    Written by Medha Baranwal Baranwal Published On 2018-12-17T20:10:24+05:30  |  Updated On 18 Aug 2021 3:28 PM IST
    Adding Aspirin to Steroid reduces Mortality in TB Meningitis - Indian Study

    Lucknow, India: Researchers at Sanjay Gandhi Post Graduate Institute of Medical Sciences, SGPGIMS, Lucknow, India have found that Aspirin with corticosteroid adjunctive therapy seems to beneficial in tuberculous meningitis (TBM) patients, through a reduction in disability and mortality. The study has been published in Neurology India.


    Stroke is prevalent in TBM patients and is associated with poor outcome. Aspirin has been known to reduce deaths in such cases. A combination of corticosteroid and aspirin may be more useful in this condition.


    Jayantee Kalita, Department of Neurology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Uttar Pradesh, India, and colleagues conducted this retrospective study to evaluate whether adjunctive treatment with corticosteroid and aspirin alone or in combination, improve outcomes for TBM.


    "Tuberculosis is a treatable and preventable disease. The prevalence of tuberculosis in India is 211/100,000 population which amounts to huge medical and social burden in India. About 35% of patients with tuberculosis is in India and China including the highest number of drug-resistant tuberculosis," Dr. Kalita told Medical Dialogues team.


    For this study, 153 patients with TBM receiving adjunctive therapies were evaluated from a prospectively maintained registry. They were divided into three groups; aspirin alone (Group I; n=44), aspirin+prednisolone (Group II, n=50), and none of the adjunctive therapies (Group III, n=41). All patients received the standard 4-drug antituberculous (rifampicin, isoniazid, pyrazinamide, and ethambutol) treatment. The clinical outcome in terms of death or disability were noted at 3 months.


    Key Findings:




    • Baseline characteristics were the same in all the patients, except meningitis was more severe in Group II.

    • After 3 months of treatment, lower death rates were noted among patients receiving adjuvant therapy compared to patients without adjuvant therapy (Group I 18.2%, Group II, 18% and Group III, 34.1%); however, the difference was not significant.

    • After adjusting for the Glasgow Coma Scale score and stage of TBM, survival was improved with combination treatment (aspirin+prednisolone) through the survival benefit was not significant.

    • Side effects were not significantly different in all the 3 groups.


    "Tuberculous meningitis (TBM) is the most severe form of tuberculosis with high mortality and severe sequelae in the survivors. Upto 60% tuberculous meningitis patients have stroke either on MRI of in autopsy. Aspirin adjunctive treatment was found to reduce mortality in TBM. In a recent report, patients receiving adjunctive use of aspirin and prednisolone in addition to antitubercular treatment had lower mortality and better 3-month outcome compared to those without this adjunctive treatment," said Dr. Kalita.


    Although the study found no significant effects on death or disability, a trend for better survival was seen with adjuvant therapy. "Corticosteroid and aspirin combination may have a favorable role in TBM by reducing death and disability, but the finding needs to be confirmed in a randomized controlled trial," concluded the authors.


    For further reference follow the link: 10.4103/0028-3886.246278
    CombinationcorticosteroiddisabilitydrugsJayantee KalitlucknowmeningitismortalityNeurology IndiaSanjay Gandhi Post Graduate Institute of Medical SciencesSGPGIMSsteroidssurvivalTBTBMtreatmenttuberculous meningitisUP
    Source : With inputs from Neurology India

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medha Baranwal Baranwal
    Medha Baranwal Baranwal
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok